Yentreve Launch Will Be Slowed By Poor Patient Awareness, Lilly Predicts
This article was originally published in The Pink Sheet Daily
Executive Summary
Lilly expects its launch of Yentreve (duloxetine) will be slowed by a lack of patient awareness about the stress urinary incontinence treatment